ECM Remodeling & Matrix Degradation Assessment Service
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Creative Biolabs provides specialized, custom-engineered 3D extracellular matrix assays, FRET-based enzymatic degradation tracking, and spatial degradomic mapping. By simulating the physical and biochemical properties of the pathological stroma in vitro, we enable research teams to evaluate target engagement, measure matrix-mediated immune evasion, and screen therapeutic compounds in physiologically relevant environments. Clients gain high-resolution, reproducible data that clarifies mechanism-of-action profiles and strengthens preclinical candidate selection long before launching in vivo animal studies.
Introduction of ECM Remodeling & Matrix Degradation Assessment
Extracellular matrix (ECM) remodeling is a core biological driver of progressive fibrosis, chronic inflammation, oncology, and cardiovascular repair. Decades of research establish that pathological microenvironments, such as the "Oncomatrix," act as active physical and biochemical shields that exclude therapeutic perfusion and silence host immunity. Impaired enzymatic clearance and aberrant cross-linking drive severe therapeutic resistance, while matrix-bound checkpoints suppress active immune surveillance. By evaluating these key biophysical and biochemical parameters, Creative Biolabs' platform delivers predictive in vitro assays that translate multi-layered cell-matrix interactions into quantitative parameters for candidate discovery.
Request a Consultation
Fig.1 Macrophage-MMP-ECM interaction in fibrosis. 1
What We Can Offer
Customized Matrix Tuning
We engineer tissue-specific, 3D biomimetic hydrogels tailored to match your target organ's mechanical stiffness and structural protein composition, establishing a physiologically relevant environment for compound evaluation.
Flexible Co-culture Configurations
We seamlessly integrate primary cells, human stroma lines, multicellular spheroids, and functional immune populations, recreating the complex cellular networks needed to analyze realistic microenvironmental responses.
Automated High-Throughput Kinetic Assays
Our platform provides continuous, automated monitoring of matrix degradation rates over time, delivering highly reproducible and scalable screening data to accelerate your preclinical candidate selection.
Ultra-Sensitive Proteomic Fingerprinting
We identify and quantify soluble remodeling fragments and neo-epitopes released during matrix breakdown, providing highly sensitive and translational biomarkers to document therapeutic activity.
How Creative Biolabs Can Assist Your Project
Highlights
Extensive Matrix Expertise
Partnering with us grants you access to decades of specialized matrix biology experience. We help your team navigate complex cell-substrate interactions, ensuring your preclinical research is guided by established scientific leaders.
Physiological Disease Representation
We preserve the native architectural, physical, and immune characteristics of diseased tissue stroma. This avoids the limitations of traditional flat screening setups, delivering results that closely replicate actual tissue conditions.
Overcoming Delivery Obstacles
Our platform helps you identify and resolve physical diffusion barriers early in development. This ensures your therapeutic candidates can successfully penetrate dense tissue barriers, optimizing downstream drug delivery evaluations.
Target-Engagement Confidence
We help your team discover reliable biomarkers and verify target binding within complex networks. This provides clear preclinical efficacy data, giving you greater confidence before moving into animal model testing.
Get a Quote Today to get a detailed project quote tailored specifically to your laboratory’s unique research objectives and discovery goals.
Customer Reviews
-
Immune Checkpoint Blockade Validation
We successfully validated our immune-checkpoint candidate molecules utilizing Creative Biolabs' specialized screening environments. Their platform yielded definitive evidence that shielding structural proteins prevents T-cell inactivation inside dense stroma matrices, restoring robust effector function to our co-cultured immune populations. - Dr. A**r. K.
-
Physiological Phagocytosis Quantification
Analyzing our anti-fibrotic compound library with Creative Biolabs resolved a key functional parameter for our project. We easily differentiated extracellular cleavage events from active cellular ingestion, establishing clear mechanism-of-action files for our leading candidates. - Dr. S**h. V.
FAQs
How does your service compare to standard 2D gelatin zymography for screening metalloproteinase (MMP) inhibitors?
Traditional zymography is an endpoint test that lacks mechanical tissue context. Our platform maintains native cell-matrix interactions using continuous screening and 3D cultures, generating highly relevant inhibitor profiles to support your preclinical development decisions.
Can you customize the ECM composition to represent specific tissue niches like fibrotic lung or cirrhotic liver?
Yes, we customize tissue environments using specific protein combinations and natural decellularized scaffolds. This allows your team to evaluate compounds within matrix conditions that closely replicate the unique biochemical features of targeted organs.
Related Services
This service monitors the dynamic activation shifts of immune cells between inflammatory and tissue-resolving states within 3D matrices, helping researchers validate compounds designed to promote native tissue repair. Learn More
Learn More →
This service examines the cellular crosstalk between activation-state macrophages and progenitor lineages within 3D cultures, enabling researchers to evaluate factors driving stem cell recruitment and lineage commitment.
Learn More →
How to Contact Us
Creative Biolabs provides an advanced in vitro framework designed to streamline target characterization and candidate screening within stroma-focused discovery pipelines. By combining biomechanical profiling, high-resolution optical imaging, and multiplexed biochemical analysis with specialized human-derived co-culture models, this service clarifies cellular-matrix interactions to guide lead selection.
Our research team is available to assist in designing, optimizing, and executing your next preclinical matrix-remodeling evaluation, please contact us.
Reference
-
Zhao, Xiangyu et al. "New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction." Cell & bioscience vol. 12,1 117. 27 Jul. 2022. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1186/s13578-022-00856-w
